Himadri Speciality Chemical schedules board meeting on 15 July to approve Q2 2026 unaudited results

What Himadri Speciality Chemical announced

Himadri Speciality Chemical Ltd (BSE: 500184) informed the Bombay Stock Exchange that its Board of Directors will convene on 15 July 2026. The primary agenda is to consider and approve the unaudited standalone and consolidated financial results for the quarter ended 30 June 2026. The notice was filed on 8 July 2026.

Board meeting details

• Date: 15 July 2026
• Venue: Registered office of Himadri Speciality Chemical Ltd (address as per statutory records).
• Purpose: Review and approve the unaudited financial statements for Q2 FY2026, both standalone and consolidated.
• Filing reference: BSE corporate filing, PDF attached to the notice (document ID: 30c876c3‑9bec‑4bb9‑b6cc‑07925543346a).

The company has not disclosed any financial numbers in this intimation; it merely signals that the formal approval of the quarter’s results is imminent.

Financial results – what is known

The filing confirms that the results to be approved are unaudited. This is a standard regulatory step in India where quarterly results are first presented to the board before audit completion. Once approved, the company will likely publish the figures on its website and through a press release, as per SEBI listing requirements.

Key facts at a glance

Why this matters for investors

The approval of quarterly results is a routine but material event. It provides shareholders with the first official snapshot of the company's performance for the quarter. Because the results are unaudited, figures may be subject to minor adjustments after the audit. Investors typically use these results to gauge revenue trends, margin stability, and cash‑flow health before the audited numbers are released. The timing also aligns with statutory disclosure norms, ensuring the company remains compliant with SEBI and BSE regulations.

Conclusion

Himadri Speciality Chemical Ltd will hold its board meeting on 15 July 2026 to approve the unaudited financial results for the quarter ended 30 June 2026. The filing does not contain the actual financial figures; those will be disclosed after board approval. Investors should await the subsequent detailed results release for a complete view of the company's Q2 performance.